Application Nr Approved Date Route Status External Links
NDA022260 2012-06-28 Intravenous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Veletri Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (pah) (who Group 1) To Improve Exercise Capacity. Studies Establishing Effectiveness Included Predominantly Patients With Nyha Functional Class Iii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah Or Pah Associated With Connective Tissue Diseases. Veletri Is A Prostanoid Vasodilator Indicated For The Treatment Of Pulmonary Arterial Hypertension (pah) (who Group 1) To Improve Exercise Capacity. Studies Establishing Effectiveness Included Predominantly Patients With Nyha Functional Class Iii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah Or Pah Associated With Connective Tissue Diseases. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Epoprostenol EPOPROSTENOL ZINC3813078

Comments